Filter
News & Insights
- Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthStartups & Innovators
From Shanghai to the world: How Asia is leading global biopharma collaboration
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthStartups & Innovators
Biogen's blueprint for collaboration in China's thriving pharma landscape
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
The art of capturing better patient data: Designing trials around the lives of patients
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
LSX World Congress Europe Panel on Oncology’s Next Frontier: Future Opportunities in an Ever-Growing Market
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Sanofi acquires Dynavax for $2.2bn, adding Hepatitis B vax and shingles candidate
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Zejing’s DLL3 cancer drug goes global with AbbVie co-sign
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Merck reportedly in talks to buy Revolution in huge $28–32bn deal
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Rumor has it: Sanofi eyes higher bid for retinal drug developer
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Double take: Novartis signs back-to-back licensing agreements
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Eikon Therapeutics sets sights on public markets
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Parabilis Medicines’ latest financing round causes IPO whispers
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Medline targets $5.37bn in landmark IPO
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Aktis Oncology sets sights on first IPO of 2026
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Biotech Showcase™ 2026 Returns to San Francisco During JPM Week as a Premier Destination for Dealmakers
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
The Funding Evolution: The Role of Alternative Financing Models in the Valley of Death
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Partnering and Fundraising: The power of presenting at Biotech Showcase
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
LSX Nordic Congress 2025 Panel
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
2025 Event Brochure
Read More